CD8A and renal cell carcinoma: As expected, CD8+ T cells in the healthy donor peripheral blood showed the biggest difference by UMAP analysis and EMD calculated between the IL-7 treatment and stimulation with CD3 alone, while in the RCC CD8+ TIL a bigger shifted was noted after treatment with combined CD3 and CD28 costimulation (Figure 4A).